|
Real-time Estimate
Cboe BZX
13:55:36 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 254.52 USD | +0.63% |
|
+5.50% | +47.06% |
| 10-28 | Evercore ISI Adjusts Price Target on Quest Diagnostics to $240 From $235 | MT |
| 10-27 | Rothschild & Co Redburn Adjusts Price Target on Quest Diagnostics to $279 From $251 | MT |
Company Valuation: Quest Diagnostics Incorporated
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21,224 | 17,817 | 15,503 | 16,838 | 19,304 | 27,826 | - | - |
| Change | - | -16.05% | -12.99% | 8.62% | 14.64% | 44.15% | - | - |
| Enterprise Value (EV) 1 | 24,364 | 21,482 | 19,683 | 22,679 | 24,555 | 32,813 | 32,163 | 31,906 |
| Change | - | -11.83% | -8.37% | 15.23% | 8.27% | 33.63% | -1.98% | -0.8% |
| P/E | 11.1x | 19.6x | 18.4x | 19.6x | 19.8x | 24.5x | 23.1x | 21x |
| PBR | 3.19x | 2.95x | 2.43x | 2.47x | 2.73x | 3.62x | 3.31x | 3.12x |
| PEG | - | -0.4x | -3.06x | 7.34x | 1.4x | 1.4x | 3.75x | 2.17x |
| Capitalization / Revenue | 1.97x | 1.8x | 1.68x | 1.71x | 1.75x | 2.3x | 2.2x | 2.12x |
| EV / Revenue | 2.26x | 2.17x | 2.13x | 2.3x | 2.23x | 2.72x | 2.55x | 2.43x |
| EV / EBITDA | 8.49x | 10.4x | 11x | 11.2x | 11.3x | 13.8x | 12.1x | 11.4x |
| EV / EBIT | 9.9x | 12.3x | 13.5x | 14.7x | 14x | 17x | 15.8x | 14.8x |
| EV / FCF | 13.3x | 16.3x | 22.8x | 24.9x | 18.1x | 27.8x | 16.2x | 19.2x |
| FCF Yield | 7.51% | 6.12% | 4.39% | 4.01% | 5.53% | 3.6% | 6.17% | 5.22% |
| Dividend per Share 2 | 2.64 | 2.64 | 2.84 | 3 | 3.2 | 3.309 | 3.294 | 3.46 |
| Rate of return | 1.53% | 1.69% | 2.06% | 1.99% | 1.84% | 1.31% | 1.3% | 1.37% |
| EPS 2 | 15.55 | 7.97 | 7.49 | 7.69 | 8.75 | 10.32 | 10.96 | 12.02 |
| Distribution rate | 17% | 33.1% | 37.9% | 39% | 36.6% | 32% | 30.1% | 28.8% |
| Net sales 1 | 10,788 | 9,883 | 9,252 | 9,872 | 11,035 | 12,084 | 12,622 | 13,142 |
| EBITDA 1 | 2,870 | 2,059 | 1,788 | 2,034 | 2,175 | 2,380 | 2,660 | 2,802 |
| EBIT 1 | 2,462 | 1,742 | 1,457 | 1,541 | 1,759 | 1,925 | 2,035 | 2,158 |
| Net income 1 | 1,995 | 946 | 854 | 871 | 992 | 1,164 | 1,237 | 1,344 |
| Net Debt 1 | 3,140 | 3,665 | 4,180 | 5,841 | 5,251 | 4,987 | 4,337 | 4,080 |
| Reference price 2 | 173.01 | 156.44 | 137.88 | 150.86 | 173.53 | 252.92 | 252.92 | 252.92 |
| Nbr of stocks (in thousands) | 122,675 | 113,887 | 112,435 | 111,615 | 111,242 | 110,019 | - | - |
| Announcement Date | 03/02/22 | 02/02/23 | 01/02/24 | 30/01/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.5x | 2.72x | 13.79x | 1.31% | 27.83B | |
| 13.14x | 0.4x | 8.38x | 2.94% | 116B | |
| 15.8x | 1.95x | 9.7x | 0.65% | 104B | |
| -303.77x | 21.22x | -358.78x | -.--% | 62.85B | |
| 27.2x | 2.37x | 13.44x | 0.79% | 29.89B | |
| 14.24x | 1.55x | 9.39x | 2.48% | 29.55B | |
| 8.22x | 1.46x | 6.64x | -.--% | 21.79B | |
| 30.62x | 5.47x | 22.33x | 2.28% | 20.66B | |
| 30.69x | 2.86x | 12.88x | 1.46% | 17.09B | |
| 14.88x | 1.4x | 7.07x | 4.74% | 13.03B | |
| Average | -12.45x | 4.14x | -25.52x | 1.67% | 44.17B | |
| Weighted average by Cap. | -28.28x | 4.50x | -42.10x | 1.53% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DGX Stock
- Valuation Quest Diagnostics Incorporated
Select your edition
All financial news and data tailored to specific country editions
